| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 25, 2022 | OSUR Orasure Technologies Inc | Aspinall Mara G. | Director | Buy | 6,000 | $4.19 | $25,137.60 | +8.4% | +18.1% | +53.7% | |
| Aug 25, 2022 | CTSO Cytosorbents Corp | Kim Jiny | Director | Buy | 1,000 | $1.91 | $1,910.00 | +1.4% | -29.0% | +20.3% | |
| Aug 25, 2022 | HBIO Harvard Bioscience Inc | Loy Bertrand69 | Director | Buy | 25,535 | $3.27 | $83,384.89 | +3.4% | -28.2% | +26.8% | |
| Aug 24, 2022 | PODD Insulet Corp | Christensen Bret | EVP And CCO | Sell | 2,900 | $264.24 | $766,296.00 | -12.9% | +5.9% | -31.4% | |
| Aug 24, 2022 | CTKB Cytek Biosciences, Inc. | Jeanmonod Patrik77 | Chief Financial Officer | Sell | 3,500 | $13.45 | $47,075.00 | -3.6% | +8.6% | -43.3% | |
| Aug 24, 2022 | VREX Varex Imaging Corp | Naumann-Etienne Ruediger | Director | Sell | 5,000 | $21.60 | $108,000.00 | -19.0% | -2.4% | -12.1% | |
| Aug 24, 2022 | RBOT Vicarious Surgical Inc. | Kelly William John85 | CFO And Treasurer | Sell | 1,247 | $3.92 | $4,893.78 | -0.2% | -8.1% | -76.1% | |
| Aug 24, 2022 | RBOT Vicarious Surgical Inc. | Khalifa Sammy84 | Chief Technology Officer | Sell | 3,734 | $3.92 | $14,653.86 | -0.2% | -8.1% | -76.1% | |
| Aug 24, 2022 | RBOT Vicarious Surgical Inc. | Sachs Adam David84 | President And CEO | Sell | 4,669 | $3.92 | $18,323.22 | -0.2% | -8.1% | -76.1% | |
| Aug 24, 2022 | RBOT Vicarious Surgical Inc. | Morris June89 | CLO, GC And Secretary | Sell | 1,233 | $3.92 | $4,838.82 | -0.2% | -8.1% | -76.1% | |
| Aug 24, 2022 | TMCI Treace Medical Concepts, Inc. | Treace John T.60 | Chief Executive Offer | Buy | 28,509 | $18.72 | $533,755.51 | +0.3% | +11.7% | -22.6% | |
| Aug 24, 2022 | TMDX Transmedics Group, Inc. | Khayal Tamer I53 | Chief Commercial Officer | Sell | 20,000 | $50.08 | $1,001,507.64 | -26.8% | +9.6% | +18.6% | |
| Aug 24, 2022 | TMDX Transmedics Group, Inc. | Hassanein Waleed H56 | President &CEO | Sell | 20,000 | $50.06 | $1,001,123.19 | -2.1% | +9.6% | +18.6% | |
| Aug 23, 2022 | DXCM Dexcom Inc | Pacelli Steven Robert57 | EVP Managing Director Dexcom V | Sell | 1,000 | $84.21 | $84,210.00 | -0.7% | +34.7% | +24.8% | |
| Aug 23, 2022 | RSCF Reflect Scientific, Inc. | Boyce Kim | CEO, CFO | Buy | 17,250 | $0.12 | $2,035.50 | - | - | - | |
| Aug 23, 2022 | HBIO Harvard Bioscience Inc | Loy Bertrand69 | Director | Buy | 13,857 | $3.21 | $44,413.85 | +2.0% | -29.3% | +33.1% | |
| Aug 22, 2022 | XAIR Beyond Air, Inc. | Gaul Michael A. | Chief Operating Officer | Buy | 2,000 | $9.42 | $18,840.00 | +3.2% | -33.1% | -70.8% | |
| Aug 22, 2022 | STSS Sharps Technology Inc. | Hayes Robert Michael | Chief Executive Officer | Buy | 4,000 | $1.29 | $5,170.00 | +3.0% | -5.6% | -36.0% | |
| Aug 22, 2022 | EKSO Ekso Bionics Holdings, Inc. | Sherman Steven72 | CEO &Chairman | Sell | 5,572 | $2.20 | $12,278.46 | -0.8% | -41.3% | -58.2% | |
| Aug 19, 2022 | AZTA Azenta, Inc. | Robertson Lindon G | EVP &Chief Financial Officer | Buy | 4,350 | $57.62 | $250,647.00 | +4.5% | +3.4% | -4.1% | |
| Aug 19, 2022 | AZTA Azenta, Inc. | McManus Matthew | EVP &Chief Operating Officer | Buy | 8,625 | $58.15 | $501,543.75 | +41.4% | +3.4% | -4.1% | |
| Aug 19, 2022 | HBIO Harvard Bioscience Inc | Loy Bertrand69 | Director | Buy | 10,759 | $3.27 | $35,185.93 | +1.6% | -28.0% | +30.8% | |
| Aug 19, 2022 | CTKB Cytek Biosciences, Inc. | Yan Ming77 | Chief Technology Officer | Sell | 20,000 | $13.62 | $272,400.00 | -0.2% | +4.2% | -38.2% | |
| Aug 18, 2022 | VREX Varex Imaging Corp | Honeysett Kimberley E.71 | SVP And General Counsel | Sell | 3,028 | $23.50 | $71,158.00 | -39.0% | -3.5% | -16.0% | |
| Aug 18, 2022 | NSPR Inspiremd, Inc. | Roubin Gary S52 | Director | Buy | 35,500 | $1.91 | $67,769.50 | +27.6% | -45.8% | +72.6% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.